APA (7th ed.) Citation

L, B., M, G., M, P., & J, T. (2020). Response to "Late relapse rates in patients with early-stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy". Journal of surgical oncology, 121(6), 1043. https://doi.org/10.1002/jso.25867

Chicago Style (17th ed.) Citation

L, Burkbauer, Goldbach M, Pomponio M, and Tchou J. "Response to "Late Relapse Rates in Patients with Early-stage Hormone Receptor Positive and HER2+ Breast Cancer Treated with Adjuvant Chemotherapy and Neoadjuvant Chemotherapy"." Journal of Surgical Oncology 121, no. 6 (2020): 1043. https://doi.org/10.1002/jso.25867.

MLA (9th ed.) Citation

L, Burkbauer, et al. "Response to "Late Relapse Rates in Patients with Early-stage Hormone Receptor Positive and HER2+ Breast Cancer Treated with Adjuvant Chemotherapy and Neoadjuvant Chemotherapy"." Journal of Surgical Oncology, vol. 121, no. 6, 2020, p. 1043, https://doi.org/10.1002/jso.25867.